drugset / Trial / NCT04021433
Ketamine for Treatment Resistant MDD
NaSingle-groupOpen-labelTreatment
Summary
This study aims to openly test the long-term safety, tolerability and effectiveness of repeated administration of IM/SC ketamine for treatment resistant MDD.
Timeline
- Start
- 2018-09-01
- Primary completion
- 2020-10-01
- Completion
- 2020-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.3 mg/kg | Intramuscular |
| Subject | Ketamine | Small molecule | 1.5 mg/kg | Intramuscular |